US equities |
MU $993.05 ▼-3.49% NVDA $225.87 ▼-1.49% META $744.42 ▲+3.58% SNDK $1,484.58 ▼-6.15% SPCX $164.11 ▲+0.95% AMD $590.21 ▼-2.94% MSFT $542.06 ▲+1.31% TSLA $379.42 ▼-0.86%
FinancialContent

Veradermics, Incorporated Common Stock (NY:MANE)

125.65 -5.25 (-4.01%)
Delayed Quote Updated: 11:42 AM EDT, Oct 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Veradermics, Incorporated Common Stock

News headline image
Veradermics Hair Loss Pill Shows Strong Phase II Signal in Women ↗
Veradermics (NYSE:MANE) said results from the female arms of Study 207, a phase II open-label trial of VDPHL01 for mild to moderate pattern hair loss, showed what company executives described as a... 
Via MarketBeat
News headline image
This Fund Has a $75 Million Bet on a Hair Loss Biotech Stock Up More Than 500% Post-IPO ↗
Veradermics develops novel dermatology treatments, targeting both adult and pediatric markets with a research-driven approach. 
Via The Motley Fool
Topics Initial Public Offering
These stocks are moving in today's session ↗
Via Chartmill
Top stock movements in today's session. ↗
Via Chartmill
These stocks are gapping in today's session ↗
Via Chartmill
Top movers in Monday's pre-market session ↗
Via Chartmill